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Background: Down syndrome is the most common chromosomal disorder, with a global incidence of 1 in 700 live births.
However, the true prevalence, associated morbidities, and health-related quality of life (HRQOL) of these individuals and their
families are not well documented, especially in low- and middle-income countries such as Pakistan. Disease-specific documentation
in the form of a collaborative registry is required to better understand this condition and the associated health outcomes. This
protocol paper describes the aims and processes for developing the first comprehensive, web-based collaborative registry for
Down syndrome in a Pakistani cohort.
Objective: This study aims to assess the HRQOL, long-term survival, and morbidity of individuals with Down syndrome by
using a web-based collaborative registry.
Methods: The registry data collection will be conducted at the Aga Khan University Hospital and at the Karachi Down Syndrome
Program. Data will be collected by in-person interviews or virtually via telephone or video interviews. Participants of any age
and sex with Down syndrome (trisomy 21) will be recruited. After receiving informed consent and assent, a series of tablet-based
questionnaires will be administered. The questionnaires aim to assess the sociodemographic background, clinical status, and
HRQOL of the participants and their families. Data will be uploaded to a secure cloud server to allow for real-time access to
participant responses by the clinicians to plan prompt interventions. Patient safety and confidentiality will be maintained by using
multilayer encryption and unique coded patient identifiers. The collected data will be analyzed using IBM SPSS Statistics for
Windows, Version 22.0 (IBM Corporation), with the mean and SD of continuous variables being reported. Categorical variables
will be analyzed with their percentages being reported and with a P value cutoff of .05. Multivariate regression analysis will be
conducted to identify predictors related to the HRQOL in patients with Down syndrome. Survival analysis will be reported using
the Kaplan-Meier survival curves.
Results: The web-based questionnaire is currently being finalized before the commencement of pilot testing. This project has
not received funding at the moment (ethical review committee approval reference ID: 2020-3582-11145).
Conclusions: This registry will allow for a comprehensive understanding of Down syndrome in low- and middle-income
countries. This can provide the opportunity for data-informed interventions, which are tailored to the specific needs of this patient
population and their families. Although this web-based registry is a proof of concept, it has the potential to be expanded to national,
regional, and international levels.
International Registered Report Identifier (IRRID): PRR1-10.2196/24901
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Down syndrome, a chromosomal disorder, is caused by the
presence of a complete or partial third copy of chromosome 21
[1]. Owing to the presence of extrachromosomal material, there
is an amplified effect on some genes, which leads to the classic
features and associated medical conditions of Down syndrome.
Patients with Down syndrome commonly present with
characteristic facial features, delayed development, and
intellectual disability [2-4]. Down syndrome is the most common
genetic cause of intellectual disability [5], with patients
experiencing cognitive impairment and difficulty in learning
[6]. Medically, patients are affected with various conditions
such as obstructive sleep apnea, congenital heart defects, and
leukemia, among others [7].
Down syndrome is prevalent in all populations, races, and
ethnicities. The Center for Disease Control reported that Down
syndrome is the most common chromosomal disorder, with an
incidence of 1 in 700 births [8]. However, data regarding the
incidence and prevalence of Down syndrome for low- and
middle-income countries (LMICs) are scant. According to one
study, 1 in 300 babies in Pakistan are diagnosed with Down
syndrome [9]. However, for a national prevalence rate, more
studies are required to compare the incidence rate in an LMIC
against high-income countries.
Health-Related Quality of Life in Patients With Down
Syndrome
Health-related quality of life (HRQOL) is an important
parameter to assess as routine clinical assessments may not
reflect the treatment burden, functional limitations, or the need
for adjustment to disability that a person may experience.
HRQOL assessment is complex as it requires understanding an
individual’s perception, experiences of their health-related
issues, and perceived level of adaptation and coping.
As Down syndrome is a chronic condition, the impact of its
related comorbidities is often lifelong and debilitating. Poor
HRQOL has been reported in patients with Down syndrome
with regard to physical, emotional, social, psychosocial, and
psychological well-being [10-12]. Although this is often
overlooked, it is important to acknowledge that Down syndrome
affects the patient’s whole family in many aspects, particularly
financially and emotionally, as additional responsibilities are
placed on the caregivers [13]. Multiple sociocultural factors can
influence caregivers’ experiences and perceptions of the
patient’s condition. For instance, a study conducted in Pakistan
reported that parents perceived Down syndrome as a
consequence of their deeds and experienced feelings of guilt
regarding it [14,15]. Furthermore, a lack of understanding about
the disease and its management added additional stress to these
parents and hampered their ability to provide care to their child
[16,17]. Early intervention, vocational therapy, and medical
management are associated with improved functioning in
children in terms of health and social outcomes [18,19].
Unfortunately, delayed diagnosis and management are common
in LMICs, with some children being diagnosed as late as age 7
[14,15]. Owing to the various region-specific difficulties, results
from studies regarding HRQOL in this population would vary
from those carried out in a resource-rich setting [13].
Challenges of Down Syndrome in LMICs
The challenges faced by LMICs regarding health care delivery
are unique and multifactorial. The obstacles include a lack of
resources, inadequate skills and training, nonstandardized
documentation, a lack of quality check frameworks, a lack of
health insurance (with patients predominantly being forced to
self-pay), and a lack of system infrastructure and support.
Patients and their caregivers often do not feel that they have the
power to verbalize what is important to them as access to any
available health care becomes the predominant concern for a
family. Furthermore, because of a lack of resources, there is a
prevailing problem of the delayed diagnosis of Down syndrome.
Pakistan, being an LMIC, has disparities in terms of health care
provision. There are health care centers where antenatal
monitoring is at par with developed countries; however, it is
not uniformly available in the sixth most populous country. To
facilitate early diagnosis, hospitals can and have started
connecting with physicians and pediatricians who can enable
the early diagnosis of Down syndrome. Unfortunately, no
registries or formal collaborations exist to highlight these unique
issues, risks, and comorbidities in Down syndrome, particularly
in Pakistan.
Rationale
Disease-specific documentation in the form of a collaborative
registry is crucial and serves an important purpose of
understanding the disease and its associated health outcomes
better. Patient-reported outcomes and patient-related experience
measures have been noted as significant parameters for the
implementation of the philosophy of Value-Based Health Care.
This will be the first comprehensive registry for Down syndrome
and its associated health problems in a Pakistani cohort. The
information regarding individuals with Down syndrome and
their families can be documented and will allow measurement
of the impact of early health care interventions and routine
medical follow-up on the well-being of individuals with Down
syndrome and their families. Subsequently, through this registry,
we can further investigate the factors affecting health care
outcomes in a large cohort. This will lead to further research to
improve interventions, offer novel treatment, and improve the
quality of care for people with Down syndrome. To date, there
are limited published data about the determinants of the
well-being of young individuals with a diagnosis of Down
syndrome, particularly in LMICs. Therefore, it is important to
JMIR Res Protoc 2021 | vol. 10 | iss. 6 | e24901 | p. 2https://www.researchprotocols.org/2021/6/e24901
(page number not for citation purposes)
Siddiqui et alJMIR RESEARCH PROTOCOLS
XSL•FO
RenderX
investigate the determinants and the associated protective factors
and risk factors affecting HRQOL in individuals with Down
syndrome and their families.
Aim
This web-based collaborative registry aims to identify the
long-term survival, morbidity outcomes, and HRQOL and the
experiences in patients with Down syndrome.
Objectives
The main objectives of this study are (1) to assess the long-term
survival, morbidity outcomes, and effects on HRQOL in patients
with Down syndrome in Pakistan and (2) to determine predictors
of HRQOL in patients with Down syndrome in Pakistan.
Methods
Study Site and Participants
This will be a prospective registry that will be conducted at the
outpatient clinic of Aga Khan University Hospital (AKUH) and
the Karachi Down Syndrome Program (KDSP). Patients of any
age and sex with Down syndrome and their families visiting
AKUH and the KDSP will be approached and invited to
participate in this collaborative registry. After giving their
informed consent and assent, patients will be interviewed in
person or remotely via a telephone call, a Zoom meeting, or
WhatsApp, as applicable. As the patients are being interviewed,
the questionnaire responses will be recorded on a smart device
controlled by the research assistant. According to the American
Academy of Pediatrics, the health supervision of children with
Down syndrome is categorized according to age [7] (Textbox
1).
Textbox 1. American Academy of Pediatrics health supervision schedule.
Birth to 1 month
• Evaluation for heart defects, feeding problems, cataracts at birth, duodenal atresia, congenital hearing loss, constipation, gastroesophageal reflux,
congenital hypothyroidism, hematological problems, and apnea.
1 month to 1 year
• Previous reports reviewed and concerns addressed (existing and new).
• Tympanometry may be ordered for detection of middle ear disease.
• 0-5 months: Ophthalmology referral to evaluate nystagmus, cataracts, and strabismus [17].
• 6 and 12 months: Thyroid function and cardiac screenings.
• Signs of neurological dysfunction or seizure.
1-5 years
• Monitor growth and development of child.
• Repeat screening for hearing impairment every 6 months and vision evaluation.
• Further evaluation for specific conditions as relevant.
• Impact of early intervention (speech, occupational, and physical therapies) reviewed.
5-13 years
• Annual visits with similar monitoring of growth and development.
• Specific attention given to evaluating age-specific BMI and maintaining healthy diet to prevent obesity.
• Evaluate social function and behavioral development of the child at this stage, both at home and during school.
This routine health care surveillance is crucial for improved
HRQOL of the patients and for the well-being of their families
[19]. We will follow up with participants in accordance with
this schedule and then schedule routine follow-ups into
adulthood to assess the patients’quality of life and health status.
The Pediatric Quality of Life (PedsQL) questionnaire forms
have been used successfully in previous studies in Pakistan, and
the patients were followed up into adulthood [20].
Web-Based Collaborative Registry
Overview
A web-based registry will be developed for data entry on the
portal, with the data being stored on a cloud server. Data entry
will occur in real time by the research assistant, and access to
the data will be restricted to relevant study team members,
physicians, or individuals involved in the care of the patient
through a login ID and password. After each data entry, a PDF
report will be generated, which can be printed and added to
patients’ medical records and viewed by the physician in real
time. The collected data can provide direction for addressing
the needs of the patients with Down syndrome and their families.
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The main registry database will reside on a central computer at
AKUH and will be managed by the study staff. A web-based
dashboard will be designed to report the registry progress. All
study staff will undergo basic research ethics training.
Participants’ information will be given a unique patient identifier
code, and no personal information will be shared.
Mobile Health Digital Platform and Data Collection
The process of gathering information (variables of interest) will
be executed in a systematic and digitized manner. All data will
be collected on smart devices (tablets, mobile phones, etc). The
data collection apps for the electronic questionnaire will be
developed using the Android Software Development Kit or
Open Data Kit, an open-source software package, and utilize
in-house front-end software for retrievable variables. The
electronic questionnaires will contain skip patterns to navigate
the user to relevant questions. Electronic case report forms will
also be loaded with valid values and specifications for valid
ranges and range checks. It will also automatically record the
start and end times of each interview, which will help monitor
and manage the interview protocol. The collected data will be
stored on the smart device and will be synchronized to AKUH
data servers through http secure. The information from the
electronic questionnaire will be uploaded to the central server
for close to real-time monitoring using the dashboard interface.
Data Management
The clinical staff, under the supervision of the principal
investigator and coinvestigators, will be responsible for
collecting the data. The clinical team collecting the data will
review them for completeness, accuracy, and visualization. The
study manager or coordinator will provide guidance to the study
staff on the corrections and edits that may be needed in the
electronic data. The registry data manager will be responsible
for the overall data management and data quality assurance.
Once the data are transferred to the central registry database,
the data management team will ensure completeness and
validity. Only the data management staff will be authorized to
make modifications to the registry database in consultation with
the program manager or study coordinator with documentation
of specific reasons. Identifiers will only be visible to the
authorized study staff.
There are 2 unique identifiers: medical record number and
registry ID number. The registry administrator and principal
investigator of the study will assign access to the study
according to the portfolio of the study staff and investigators.
For example, physicians will have full access to clinical data
and limited access to research data and vice versa for research
staff. However, the principal investigator and nominated
investigators of the study will have full access to the clinical
and research data.
Data Security
All the devices used for collecting data will be password
protected. Only designated personnel will have access to these
data for monitoring and operational purposes. All data collected
on handheld devices as well as during transmission will be
encrypted using the Rivest-Shamir-Adleman encryption. Weekly
data backup will be scheduled on a different machine, and
off-site backups will occur at regular intervals. This web-based
registry is an electronic portal consisting of multiple dashboards
to keep track of the registry database in real time and visualize
the progress of the study at a glance. It will be hosted on a
Google Cloud server with multiple layers of encryption to ensure
rigorous security practices against threats to the infrastructure
from both internal and external factors. Access to sensitive data
will be protected by advanced tools, whereas database and file
storage will be protected by AES256 or AES128 encryption.
This will help in guarding against unauthorized access and
service interruptions.
Recruitment Process
Eligible patients with Down syndrome and their parents or
guardians visiting the genetics clinic at AKUH and at the KDSP
will be approached to participate in the registry. AKUH is one
of the only Joint Commission International–certified tertiary
care centers in Pakistan. Patients from all over the country and
the international community come to receive state-of-the-art
care at this leading hospital. The KDSP is a nonprofit
organization formed by parents and passionate individuals
interested in improving the lives of children with Down
syndrome, with a focus on occupational therapy and improving
their quality of life [21]. This collaboration allows an insight
into not only the health care perspective but also the child’s
community and social support. In addition, patients who are not
scheduled for a clinic visit will be approached through a
telephone call, a Zoom meeting, or WhatsApp to minimize
patient exposure in the light of the COVID-19 pandemic. The
participants will be provided with information related to the
registry. An interview slot will be allocated to interested eligible
patients and their parents to schedule their interviews. Informed
consent will be obtained from patients and their [22] parents
both verbally and in writing when applicable, with a witness
present when consent is obtained remotely, before the
commencement of the interview. Participants will be offered a
choice to receive that information in English or Urdu, the latter
being the nationally spoken language of Pakistan. Assent will
also be obtained from patients aged 7 to 18 years, with a witness
being present. A copy of the informed consent and assent will
be provided to the participants. The interviews will consist of
a series of tablet-based questionnaires. The interviews will be
conducted at the KDSP, in a designated room in the clinical
trials unit at the AKUH, or remotely. When conducted remotely,
the research assistant will record the participant responses on
an electronic questionnaire, which will be automatically saved
to the web-based registry platform.
Data Collection
Baseline surveys regarding the sociodemographic variables,
clinical history, outcomes, and health information of the patient
will be administered to the patients or their caregivers by a
research assistant. The baseline survey form has been developed
based on the intake form used by clinicians and researchers at
the National Institute of Health’s Down Syndrome Registry,
which is publicly available through DS-Connect [23], and
Children’s Hospital of Boston Down Syndrome clinic, which
provided the information after an email request. The questions
have been screened and modified by experts in the fields of
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genetics and pediatric development. Trained staff will conduct
the interviews using a tablet. Business rules, consistency checks,
and skips will be incorporated, and important fields will be
marked as a must to enter.
The PedsQL generic core (physical, emotional, social,
psychosocial, and school or work domains), PedsQL Cognitive
scale (cognitive functioning), and PedsQL general well-being
questionnaires will be used to explore HRQOL. These
questionnaires have been widely used in other settings to explore
HRQOL [24]. The PedsQL Family Impact Module (physical,
emotional, social, cognitive, communication, concerns related
to the child, daily activities, and family relationship) will be
used to explore the impact of Down syndrome on the family as
a unit. In addition, the PedsQL Health Satisfaction Generic
Module (information, family inclusion, communication,
technical skills, emotional needs, and overall satisfaction) will
be explored by the parents. All these questionnaires have
well-established validities and reliabilities [25]. They are
available for populations of different ages as well as their parents
or proxies for young children (5-7 years), children (8-12 years),
teenagers (13-18 years), young adults (18-25 years), and adults
(>26 years). There is also a guardian or parent version only for
toddlers (2-4 years), given the developmental limitations on
self-reporting for children younger than 5 years.
All the age-relevant questionnaires will be administered when
the participants are enrolled at their initial interview. At the
conclusion of a questionnaire pertaining to HRQOL, a score is
generated. On the basis of a preset cutoff, the registry algorithm
will alert the interviewer at the next follow-up that a particular
questionnaire needs to be re-administered. If the participant’s
score is above the cutoff of 80, the algorithm will inform the
interviewer of the need to repeat the particular questionnaire in
2 to 3 years. The scores of each questionnaire will be assessed
independently. The follow-up timing of each patient depends
on their age cohort (Figure 1). Follow-up appointments can
continue into adulthood as there are specific PedsQL
questionnaires designed for adult participants. Given the
frequent follow-up appointments, financial constraints on
patients and their families must be considered in a
resource-constrained setting. In Pakistan, AKUH along with
other nongovernment organizations are offering web-based
consultations on subsidized clinical charges. Even when full
charges are being received, web-based consultations allow
families to save on the cost of traveling. To make it sustainable,
our children’s hospital has pediatric welfare funds that can help
ease the financial burden.
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Figure 1. Web-based registry questionnaire administration algorithm. Forms attached—Form 1: initial baseline intake form; Form 2: follow-up intake
form; Form 3: family report; Form 4: health care satisfaction; Form 5: general well-being; Form 6: cognitive functioning scale; and Form 7: Pediatric
Quality of Life inventory. *Assess score of each form independently and base decision of administering form again at follow-up appointment on cutoff
scores.
Data will be collected in real time using a tablet-based
questionnaire. The data will be collected from the patient (≥5
years), their parents or guardians (for patients aged 2-18 years),
and from patient files as applicable. Once collected, the data
will be uploaded to the cloud server and stored in the patient’s
individual folder based on their unique identification number.
The stored data can be summarized in the form of an
automatically generated PDF to aid with the following
physician-patient interaction, and notifications regarding
anomalies or upcoming forms required will be alerted (Figure
2). Details of the variables, their sources, and the questionnaires
used, including sociodemographic variables, family history,
birth history, immunization history, developmental history,
medical history, comorbidities, medications, physical
examination, health care utilization, functional status, and impact
on family, are given in Table 1.
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Figure 2. Web-based registry data pathway.
Permission to use the PedsQL HRQOL questionnaires has been
obtained. These questionnaires were originally in English and
have been translated to Urdu and then back-translated by an
expert panel. Any discrepancies with the translation will be
reported. The form will then be pretested for content and face
validities. The final version will then be submitted to Mapi
Research (PedsQL parent organization) along with the whole
translation report. Differences in the Pakistani population are
anticipated, and modifications to the PedsQL forms can be
suggested to the parent organization following pilot testing. For
patients who were already being treated at AKUH and the
KDSP, the clinical notes on the file can be used retrospectively
to gather more data regarding the participant.
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Table 1. Variables included in quality-of-life assessment using self-developed form as a data collection tool.




Patient, parents, siblingFamily income
Patient, parents, siblingFamily structure, number of members
Patient, parents, siblingEthnicity




ParentsHistory of any chromosomal abnormality or disability
Birth history
ParentsAnthropometrics, parental age, delivery details etc
Immunization history
Parents, immunization cardBirth till current immunization as per EPIa
Developmental history
ParentsWalking, feeding, speech, etc
Medical history of patient (Down syndrome)




ParentsSurrogate for health status
Physical examination
Physician or medical record fileGastrointestinal, CVSb, CNSc, musculoskeletal, skin, genitourinary, allergies
Health care utilization
ParentsNumber of hospitalizations, surgical procedures, number of hospital visits, interventions, therapy, services
utilized, cost of each therapy and visit, payment mode (self, insurance, philanthropist, hospital finance
assistance, etc)
Functional status
Patient or parentPhysical, emotional, social, and psychosocial status and school or work
Patient or parentCognition
Patient or parentGeneral well-being
Impact on the family
ParentsParental QOLd
ParentsFamily functioning
ParentsSatisfaction with the health care received or receiving
aEPI: Expanded Program on Immunization.
bCVS: cardiovascular system.
cCNS: central nervous system.
dQOL: quality of life.
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The data will be exported to SPSS version 22 (IBM Corporation)
for analysis. For descriptive analysis, the number of participants
enrolled, mean and SD of continuous variables, and percentages
for the categorical variables will be reported.
The HRQOL and health care utilization questionnaires have
very similar response items and scoring. These questionnaires
will capture patients’ experiences in the preceding month. Both
patients and parents will be asked to rate their HRQOL from 0
to 4, with 0 being “never a problem” and 4 being “almost always
a problem.” Responses will be reverse scored and linearly
transformed to 0-100, with higher scores indicating better
HRQOL. If more than 50% of the items in the scale are missing,
the scale scores will be considered as missing data. The mean
score of the individual domains will be calculated by adding
the sum of the items to the number of items answered. The total
score will be the sum of all the items over the number of items
answered on all scales.
The registry will also identify the predictors of HRQOL in the
patients with Down syndrome. For all predictor variables
(sociodemographic and clinical parameters), the univariate
analysis will be performed with the HRQOL domains. Studies
have shown that in older patients with Down syndrome, poor
HRQOL was reported because of health problems, limited social
relationships, and restricted educational and employment
opportunities [12,26]. However, although there are data
regarding parent-reported HRQOL [27] and even HRQOL of
parents of children with Down syndrome [27], there are very
limited data regarding self-reported HRQOL in children with
Down syndrome. Each predictor variable will be regressed
against the HRQOL variable to assess the eligibility of a
predictor variable to be included in the final model. The criteria
for inclusion of a predictor variable will be set at a P value
cutoff of .25 at the univariate analysis level. Insignificant
variables that do not meet the cutoff criterion will be removed
from the model at the univariate analysis level. The significant
variables will then be assessed for multicollinearity. In the
multivariable regression analysis stage, the cutoff for the P
value will be set at .05. Variables will be added to the model
until the overall model remains significant through the manual
stepwise model-building technique. After the multivariable
analysis, the interaction will be assessed among the predictor
variables. The cutoff at this stage will be set at .1. For a predictor
variable to have an interactive effect with another variable, the
P value of the respective variables should be less than or equal
to the set cutoff, that is, .1. Observations of the significant
variables will also be vetted for outliers.
The Kaplan-Meier survival curves will be used to report survival
status. Survival will be analyzed for the cohort with respect to
variables such as age, sex, and comorbidities, with P<.05 being
accepted as statistically significant.
Ethical Considerations
The registry has received approval from the ethics review
committee at AKUH, Pakistan. Informed consent will be
obtained from patients and their parents both orally and in
writing, and participants will be offered a choice to receive that
information in English or Urdu. Assent will also be obtained
from patients aged 5 to 18 years. The study participants will
have a unique identifier to maintain patient confidentiality.
Original and backup files will be archived in password-protected
computers or servers at AKUH. Data confidentiality will be
maintained at all times. No personal identifiers will be used in
any reports or publications of this study. No individual
identifiers such as names of participants or areas of location
will be shared. Although the risks associated with this study are
negligible, it is possible that participants may become distressed
while telling their story. In this instance, we will follow the
participant distress protocol developed for this study. Data
confidentiality and archiving will be maintained according to
the Good Clinical Practice Guidelines. Data findings will be
disseminated through peer-reviewed publications and
presentations at national and international conferences.
Results
This study was approved by the AKUH Ethics Review
Committee (Reference ID: 2020-3582-11145). Currently, no
funding is available, but opportunities are being explored.
Furthermore, we are preparing to begin pilot testing of the
registry by September 2021.
Discussion
Benefits of a Patient Registry
In recent years, the utilization of technology has profoundly
impacted and benefited patient care. The dearth of information
available at a moment’s notice allows the practice of
evidence-based medicine and provides the ability to monitor
trends and patterns. A significant source of this information is
from biobanks and data registries, and with the use of technology
and web-based designs, these data can be accessed in real time.
The true beneficiaries of data registries are the patients as the
increased information allows for patient-centered care and
real-time decisions that can impact patient lives [28]. A majority
of registries are formed and operated in high-income countries,
where there is the presence of established health care systems
to ease patients with respect to costs and follow-up appointments
and the invaluable use of electronic health records. However,
although they face unique challenges and obstacles [29], a
number of registries are being successfully operated in LMICs
[30,31], and the data obtained have a great impact on patient
care and further research in a setting where there is a lack of
availability of organized data.
Limitations
At its conception, this registry was reliant on regular patient
follow-ups at the AKUH and KDSP. However, in Pakistan, the
majority of patients do not have health insurance. This results
in out-of-pocket payments for doctors’ appointments, testing,
and procedures, which are often too taxing on the patient’s
family. Furthermore, because of a scarcity of resources, there
are few tertiary care centers where the needs of children with
Down syndrome can be addressed. This results in further
expenses as families need to travel far distances to receive care.
Together, these problems create a large pool of patients who
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are lost to follow-up. In light of the COVID-19 pandemic, we
further anticipate that patients will be reluctant to visit hospitals
for interviews or regular checkups. We have used technology
to bridge these deficits, with web-based consultations being
carried out at a reduced fee at the KDSP with AKUH doctors
to ensure that patients can be evaluated regularly from remote
areas. Furthermore, the option for interviews via telephone calls
or video calls is available, which we anticipate will make
interviews more accessible to patients and their families.
Concerns that arise from telephone interviews, such as a lack
of facial cues regarding a patient or their family’s comfort level,
are intended to be mitigated by the use of video call tools as
well.
Strengths
Being the first registry for patients with Down syndrome in
Pakistan, the project offers insight into the demographics,
morbidity, mortality, and economic burden for this patient
cohort. This information is rarely available in LMICs, as cases
are underreported and undertreated. These data can create an
opportunity for region-specific interventions and changes that
can address the specific problems faced by this population.
Furthermore, through the web-based design, the registry offers
a unique opportunity for physicians to receive real-time data
regarding the patient’s HRQOL, development, and general
health based on extensive questionnaires. Often, this information
could be missed in a regular patient consultation because of
time constraints. With this information, physicians can
implement immediate interventions to reduce any difficulties
or stressors experienced by the patient and their family, creating
true patient-centered care.
Conclusions
With the development of a Down syndrome registry, the
opportunity to study Pakistan-specific trends in patients with
Down syndrome presents itself. Given the vast differences in
culture, social, and economic situations, discrepancies are
expected between the quality of life of patients in LMICs and
high-income countries. However, the assessment of HRQOL
and patient-reported outcomes will allow us to see how this
condition affects patients, how they and their families view their
condition, and what their specific concerns are. This will allow
the implementation of patient-centered care, a concept that is
highly acclaimed yet often lacking in LMICs. This information
will prove invaluable for implementation and influencing
decisions for other patient populations with demographics
similar to those seen in Pakistan. Although this study is currently
limited to 2 centers in a major city of Pakistan, with the
collection of data and initiation of this project, we are confident
in the ability to procure funding soon to expand the project to
regional, national, and eventually international levels.
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